Dr. Guinan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue
Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-4932Fax+1 617-632-3770- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1984 - 1986
- Dana-Farber Cancer InstituteResidency, Pediatrics, 1982 - 1984
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1980 - 1982
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- MA State Medical License 1984 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors for Cancer Castle Connolly, 2011-2024
- Boston Magazine Castle Connolly, 2010-2024
- America's Top Doctors Castle Connolly, 2009-2024
Clinical Trials
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy Start of enrollment: 2000 Feb 01
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant Start of enrollment: 2005 Jun 01
- Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Start of enrollment: 2007 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsDonor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial.Eva C Guinan, Laura Contreras-Ruiz, Kerry Crisalli, Charles Rickert, Ivy Rosales, Robert Makar, Robert Colvin, Edward K Geissler, Birgit Sawitzki, Paul Harden, Qizhi T...> ;American Journal of Transplantation. 2023 Dec 1
- 2 citationsExpanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases.Larisa Broglie, Brian D Friend, Saurabh Chhabra, Brent R Logan, Caitrin Bupp, Gary Schiller, Bipin N Savani, Edward Stadtmauer, Allistair A Abraham, Mahmoud Aljurf, Sh...> ;Transplantation and Cellular Therapy. 2023 Feb 1
- 4 citationsEx vivo generation of regulatory T cells from liver transplant recipients using costimulation blockadeKatsuyoshi Shimozawa, Laura Contreras-Ruiz, Sofia Sousa, Ruan Zhang, Urvashi Bhatia, Kerry C Crisalli, Lisa L. Brennan, Laurence A. Turka, James F. Markmann, Eva C. Gu...> ;American Journal of Transplantation. 2021 Sep 15
- Join now to see all
Journal Articles
- The Open Translational Science in Schizophrenia (OPTICS) Project: An Open-Science Project Bringing Together Janssen Clinical Trial and NIMH DataEva C Guinan, Joseph S Ross, Adam J Savitz, Nature
Press Mentions
- Can AI Tools Segment A Cancer Tumor as Well as an Oncologist?May 21st, 2019
- Harvard, Dana-Farber AI Challenge Uses Crowdsourcing to Improve Cancer CareApril 18th, 2019
- Scientists Are Training the Body to Accept New OrgansJanuary 22nd, 2019
- Join now to see all
Grant Support
- rBPI21: Development of a novel radiation mitigatorDARPA2012–Present
- In Vivo Irradiations With Patients Undergoing Radiation Therapy: DANA Farber CancNational Institute Of Allergy And Infectious Diseases2010–2011
- Potential Role of rBPI21 in Ameliorating Radiation Toxicity: A Murine ModelDARPA2008–2011
- Ex Vivo Alloanergization To Improve Immunity After Haploidentical TransplantNational Cancer Institute2009–2010
- Rbpi21 &Endotoxin-Directed Innate Immunity In Stem Cell TransplantationNational Heart, Lung, And Blood Institute2008–2009
- Endotoxin-directed Innate Immunity in Patients Undergoing Hematopoietic Stem Cell TransplantationDana Foundation2007–2009
- Clinical CoreNational Cancer Institute2008
- Cellular Correction Of Congenital Hematopoietic DisordersNational Heart, Lung, And Blood Institute2000–2002
- Centers For Clinical Research On TransplantationDivision Of Blood Diseases And Resources1998–2000
- Phase I/II Study Of Pixy 321 For Patients With Marrow Failure SyndromesNational Center For Research Resources1996–1997
- Phase I/II Trial Of Pixy-321 For Patients With Amegakarypcytic ThrombocytopeniaNational Center For Research Resources1996
- Phase I Study Of Recombinant Human Interleukin 11National Center For Research Resources1996
Professional Memberships
- Member
- American Society of Pediatric Hematology OncologyMember
- American Society for Blood and Marrow TransplantationMember
- International Pediatric Transplant AssociationMember
Other Languages
- Swedish
Hospital Affiliations
- Boston Children's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: